Hi, we've made some changes

Merck Co Inc(MRK)

Sector:

Health Care and Related Services

Index:

Dow Jones I.A.

Market Cap

$81,100m

Change Today

Price Up$0.36

Share Price

$37.33

Merck Co Inc Overview

US drugmaker, Merck & Co, is a leading global research-driven pharmaceutical products and services company. The company discovers, develops, manufactures and markets a broad range of innovative products to improve human and animal health, directly and through its joint ventures. Its products, generally sold by prescription, include therapeutic and preventive agents for the treatment of human disorders and animal health supplies. The company’s products are sold, primarily, to drug wholesalers and retailers, hospitals, clinics, government agencies and managed healthcare providers, such as health maintenance organisations and other institutions.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Income & Efficiency

Latest F'cast
Div Yield 4.1% 4.4%
Div Cover 1.0 1.9
Op Mrgn 13.9% 37.0%
ROCE 13.9%  

Valuation

Latest F'cast
P/E 24.5 11.4
PEG n/a 0.1
Pr/Revenue 3.3 3.3
Pr/Book 3.9  

Growth

Latest F'cast
Revenue 6.9% 0.1%
PBT -45.8% 166.0%
EPS -26.0% 115.8%
DPS n/a 11.5%

Merck Co Inc Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-03 22,485.90 9,051.60 295.00¢ 15.7 n/a -2% 146.00¢ 3.2%
31-Dec-04 22,938.60 7,974.50 262.00¢ 12.3 n/a -11% 150.00¢ 4.7%
31-Dec-05 22,011.90 7,363.90 211.00¢ 15.1 n/a -20% 152.00¢ 4.8%
31-Dec-06 22,636.00 6,221.40 204.00¢ 21.4 n/a -3% 152.00¢ 3.5%
31-Dec-07 24,197.70 3,370.70 151.00¢ 38.5 n/a -26% 152.00¢ 2.6%

Merck Co Inc Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-08 24,221.80 8,967.11 325.79¢ 11.3 0.1 +116% 169.45¢ 4.4%
31-Dec-09 25,616.49 10,269.93 363.49¢ 10.2 0.9 +12% 156.77¢ 4.1%

Covering analysts: Actual, Argus Research, Bernstein Research, BMO Capital Markets US, Citigroup Investment Research, Credit Suisse, Deutsche Bank Research, Goldman Sachs, Hilliard Lyons, HSBC Securities, JP Morgan, Leerink Swann & Co, Lehman Bros, Merrill Lynch, Natixis Securities, Standard & Poors, UBS

Merck Co Inc Top Newspaper Links

Merck wins; court denies suit from healthy Vioxx... 05-Jun-2008 USA Today
Court limits Vioxx monitoring payments by Merck 05-Jun-2008 Chicago Tribune
Appeals courts back Merck in Vioxx cases 30-May-2008 USA Today

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 20 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

Merck Co Inc Market Data

Currency US Dollars
Share Price $37.33  
Change Today $0.36
52 Week High $61.25
52 Week Low $34.68
Volume 356,154
Shares Issued 2,172.50m
Market Cap $81,100m
Beta 0.63
RiskGrade 174

What The Brokers Say

Strong Buy 9
Buy 1
Neutral 7
Sell 0
Strong Sell 0
Total 17
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Merck Co Inc Dividends

No dividends found

Trades for 09-Jul-2008

Time Volume / Share Price
09:37 2 @ $37.33
09:37 2 @ $37.33
09:37 2 @ $37.33
09:37 1 @ $37.33
09:37 2 @ $37.31

Digital Look have been voted
"Best Research and Information Provider"

4th Floor, Bankside House, 107 Leadenhall Street, London EC3A 4AF.
Registered in England and Wales (registered no. 3678570).